BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35073946)

  • 21. NUP98-BPTF gene fusion identified in primary refractory acute megakaryoblastic leukemia of infancy.
    Roussy M; Bilodeau M; Jouan L; Tibout P; Laramée L; Lemyre E; Léveillé F; Tihy F; Cardin S; Sauvageau C; Couture F; Louis I; Choblet A; Patey N; Gendron P; Duval M; Teira P; Hébert J; Wilhelm BT; Choi JK; Gruber TA; Bittencourt H; Cellot S
    Genes Chromosomes Cancer; 2018 Jun; 57(6):311-319. PubMed ID: 29427526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Smarca5-mediated epigenetic programming facilitates fetal HSPC development in vertebrates.
    Ding Y; Wang W; Ma D; Liang G; Kang Z; Xue Y; Zhang Y; Wang L; Heng J; Zhang Y; Liu F
    Blood; 2021 Jan; 137(2):190-202. PubMed ID: 32756943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NUP98 is rearranged in 3.8% of pediatric AML forming a clinical and molecular homogenous group with a poor prognosis.
    Struski S; Lagarde S; Bories P; Puiseux C; Prade N; Cuccuini W; Pages MP; Bidet A; Gervais C; Lafage-Pochitaloff M; Roche-Lestienne C; Barin C; Penther D; Nadal N; Radford-Weiss I; Collonge-Rame MA; Gaillard B; Mugneret F; Lefebvre C; Bart-Delabesse E; Petit A; Leverger G; Broccardo C; Luquet I; Pasquet M; Delabesse E
    Leukemia; 2017 Mar; 31(3):565-572. PubMed ID: 27694926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nup98 recruits the Wdr82-Set1A/COMPASS complex to promoters to regulate H3K4 trimethylation in hematopoietic progenitor cells.
    Franks TM; McCloskey A; Shokirev MN; Benner C; Rathore A; Hetzer MW
    Genes Dev; 2017 Nov; 31(22):2222-2234. PubMed ID: 29269482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CDK6 is an essential direct target of NUP98 fusion proteins in acute myeloid leukemia.
    Schmoellerl J; Barbosa IAM; Eder T; Brandstoetter T; Schmidt L; Maurer B; Troester S; Pham HTT; Sagarajit M; Ebner J; Manhart G; Aslan E; Terlecki-Zaniewicz S; Van der Veen C; Hoermann G; Duployez N; Petit A; Lapillonne H; Puissant A; Itzykson R; Moriggl R; Heuser M; Meisel R; Valent P; Sexl V; Zuber J; Grebien F
    Blood; 2020 Jul; 136(4):387-400. PubMed ID: 32344427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Molecular Characteristics and Clinical Features of Adults with
    Lun Y; Huang JC; Long D; Wang FF; Dai Y; Yang Y; Zhao TT; Li Q; Wu Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jul; 49(4):575-581. PubMed ID: 30378313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional analysis of the NUP98-CCDC28A fusion protein.
    Petit A; Ragu C; Soler G; Ottolenghi C; Schluth C; Radford-Weiss I; Schneider-Maunoury S; Callebaut I; Dastugue N; Drabkin HA; Bernard OA; Romana S; Penard-Lacronique V
    Haematologica; 2012 Mar; 97(3):379-87. PubMed ID: 22058212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NUP98-NSD1 gene fusion and its related gene expression signature are strongly associated with a poor prognosis in pediatric acute myeloid leukemia.
    Shiba N; Ichikawa H; Taki T; Park MJ; Jo A; Mitani S; Kobayashi T; Shimada A; Sotomatsu M; Arakawa H; Adachi S; Tawa A; Horibe K; Tsuchida M; Hanada R; Tsukimoto I; Hayashi Y
    Genes Chromosomes Cancer; 2013 Jul; 52(7):683-93. PubMed ID: 23630019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined treatment with venetoclax, dasatinib, and FLT3 inhibitors for NUP98-NSD1+/FLT3-ITD+ acute myeloid leukemia: A pediatric case report.
    Wen X; Wu Y; Huang P; Zheng H
    Pediatr Blood Cancer; 2023 Jul; 70(7):e30308. PubMed ID: 36965174
    [No Abstract]   [Full Text] [Related]  

  • 30. Mechanistic insights into chromatin targeting by leukemic NUP98-PHF23 fusion.
    Zhang Y; Guo Y; Gough SM; Zhang J; Vann KR; Li K; Cai L; Shi X; Aplan PD; Wang GG; Kutateladze TG
    Nat Commun; 2020 Jul; 11(1):3339. PubMed ID: 32620764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nizp1 is a specific NUP98-NSD1 functional interactor that regulates NUP98-NSD1-dependent oncogenic programs.
    Berardi A; Botrugno OA; Quilici G; Manteiga JMG; Bachi A; Tonon G; Musco G
    FEBS J; 2023 Apr; 290(7):1782-1797. PubMed ID: 36271682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutated
    Niktoreh N; Walter C; Zimmermann M; von Neuhoff C; von Neuhoff N; Rasche M; Waack K; Creutzig U; Hanenberg H; Reinhardt D
    J Oncol; 2019; 2019():1609128. PubMed ID: 31467532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Candidate genes for expansion and transformation of hematopoietic stem cells by NUP98-HOX fusion genes.
    Palmqvist L; Pineault N; Wasslavik C; Humphries RK
    PLoS One; 2007 Aug; 2(8):e768. PubMed ID: 17712416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Critical role of retinoid/rexinoid signaling in mediating transformation and therapeutic response of NUP98-RARG leukemia.
    Qiu JJ; Zeisig BB; Li S; Liu W; Chu H; Song Y; Giordano A; Schwaller J; Gronemeyer H; Dong S; So CW
    Leukemia; 2015 May; 29(5):1153-62. PubMed ID: 25510432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The MLL-Menin Interaction is a Therapeutic Vulnerability in
    Rasouli M; Blair H; Troester S; Szoltysek K; Cameron R; Ashtiani M; Krippner-Heidenreich A; Grebien F; McGeehan G; Zwaan CM; Heidenreich O
    Hemasphere; 2023 Aug; 7(8):e935. PubMed ID: 37520776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential requirements for Smarca5 expression during hematopoietic stem cell commitment.
    Turkova T; Kokavec J; Zikmund T; Dibus N; Pimkova K; Nemec D; Holeckova M; Ruskova L; Sedlacek R; Cermak L; Stopka T
    Commun Biol; 2024 Feb; 7(1):244. PubMed ID: 38424235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Covalent inhibition of NSD1 histone methyltransferase.
    Huang H; Howard CA; Zari S; Cho HJ; Shukla S; Li H; Ndoj J; González-Alonso P; Nikolaidis C; Abbott J; Rogawski DS; Potopnyk MA; Kempinska K; Miao H; Purohit T; Henderson A; Mapp A; Sulis ML; Ferrando A; Grembecka J; Cierpicki T
    Nat Chem Biol; 2020 Dec; 16(12):1403-1410. PubMed ID: 32868895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening for NUP98 rearrangements in hematopoietic malignancies by fluorescence in situ hybridization.
    Nebral K; König M; Schmidt HH; Lutz D; Sperr WR; Kalwak K; Brugger S; Dworzak MN; Haas OA; Strehl S
    Haematologica; 2005 Jun; 90(6):746-52. PubMed ID: 15951287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetic control of SPI1 gene by CTCF and ISWI ATPase SMARCA5.
    Dluhosova M; Curik N; Vargova J; Jonasova A; Zikmund T; Stopka T
    PLoS One; 2014; 9(2):e87448. PubMed ID: 24498324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of acute myeloid leukemia in mice by the human leukemia-specific fusion gene NUP98-HOXD13 in concert with Meis1.
    Pineault N; Buske C; Feuring-Buske M; Abramovich C; Rosten P; Hogge DE; Aplan PD; Humphries RK
    Blood; 2003 Jun; 101(11):4529-38. PubMed ID: 12543865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.